A new vaccine is offering hope for people fighting an aggressive form of breast cancer. Dr. Michael Daignault talks about ...

Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with triple-negative breast cancer, according to a study published online Nov. 14 in Genome ...

A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some ...

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with ...

More than a third of surgical patients develop complications as a result of their procedure, a new study shows.

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

A trial of the vaccine showed it to be "well-tolerated" and to stimulate the immune system. The post New vaccine shows ...

Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of the ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

Presentation of breast cancer peptides to T cells through these vaccines can ... A randomized phase I study will determine the impact of a neoantigen vaccine plus durvalumab among patients with ...